Table 2 Anticoagulation and Antiplatelet Pre-injury Use (n = 218)
From: Delayed intracranial hemorrhage in elderly anticoagulated patients sustaining a minor fall
ACAP Therapy | n (%) |
|---|---|
Warfarin (Coumadin and Marevan) | |
Yes | 72 (33.03%) |
No | 146 (66.97%) |
Dabigatran (Pradaxa) | |
Yes | 6 (2.75%) |
No | 212 (97.25%) |
Apixaban (Eliquis) | |
Yes | 11 (5.05%) |
No | 207 (94.95%) |
Rivaroxaban (Xarelto) | |
Yes | 13 (5.96%) |
No | 205 (94.04%) |
Dipyridamole (Aggrenox) | |
Yes | 4 (1.83%) |
No | 214 (98.17%) |
Enoxaparin (lovenox) | |
Yes | 2 (0.92%) |
No | 216 (99.08%) |
Heparin | |
Yes | 0 (0.00%) |
No | 218 (100.00%) |
Ticagrelor (Brilinta) | |
Yes | 0 (0.00%) |
No | 218 (100.00%) |
Aspirin | |
Yes | 118 (54.13%) |
No | 100 (45.87%) |
Clopidogrel (Plavix) | |
Yes | 36 (16.51%) |
No | 182 (83.49%) |
Prasugrel (Effient) | |
Yes | 0 (0.00%) |
No | 218 (100.00%) |
Ticlopidine (Ticlid) | |
Yes | 0 (0.00%) |
No | 218 (100.00%) |